本页面由Tiger Trade Technology Pte. Ltd.提供服务

Sutro Biopharma Inc

13.28
-0.9900-6.94%
成交量:29.87万
成交额:394.70万
市值:2.20亿
市盈率:-0.76
高:14.21
开:14.08
低:12.83
收:14.27
52周最高:43.85
52周最低:7.15
股本:1,656.72万
流通股本:1,076.62万
量比:1.14
换手率:2.77%
股息:- -
股息率:- -
每股收益(TTM):-17.3700
每股收益(LYR):-22.4900
净资产收益率:-1810.01%
总资产收益率:-36.08%
市净率:-2.13
市盈率(LYR):-0.59

数据加载中...

2024/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

重要事件披露

Form 8-K - Current report
2024/11/12

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/04

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

重要事件披露

Form 8-K - Current report
2024/08/12

重要事件披露

Form 8-K - Current report
2024/06/10

重要事件披露

Form 8-K - Current report
2024/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/13

重要事件披露

Form 8-K - Current report
2024/04/05

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/02

重要事件披露

Form 8-K - Current report
2024/04/02

重要事件披露

Form 8-K - Current report
2024/03/25

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/25

重要事件披露

Form 8-K - Current report
2024/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

重要事件披露

Form 8-K - Current report